Evidence map›Paper›PMID 38842632›Full record

ReviewCurrent diabetes reports2024

Review Article - Diabetes Technology in the Hospital: An Update.

Margaretha M Visser, Roman Vangoitsenhoven, Pieter Gillard, Chantal Mathieu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Inpatient Use of Automated Insulin Delivery Systems.Journal of diabetes science and technology · 2026
    Review
  3. Article
  4. Article
  5. Association Between Daily Insulin Dose Adjustments and Glycemic Control in Noncritically Ill Hospitalized Hyperglycemic Patients: A Retrospective Cohort Study.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Margaretha M VisserDepartment of Endocrinology, University Hospitals Leuven, Louvain, Belgium.ORCID http://orcid.org/0000-0003-0216-4028
Roman VangoitsenhovenDepartment of Endocrinology, University Hospitals Leuven, Louvain, Belgium.ORCID http://orcid.org/0000-0003-3523-669X
Pieter GillardDepartment of Endocrinology, University Hospitals Leuven, Louvain, Belgium.ORCID http://orcid.org/0000-0001-9111-4561
Chantal MathieuDepartment of Endocrinology, University Hospitals Leuven, Louvain, Belgium. chantal.mathieu@uzleuven.be.ORCID http://orcid.org/0000-0002-4055-5233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThere have been many developments in diabetes technology in recent years, with continuous glucose monitoring (CGM), insulin pump therapy (CSII) and automated insulin delivery (AID) becoming progressively accepted in outpatient diabetes care. However, the use of such advanced diabetes technology in the inpatient setting is still limited for several reasons, including logistical challenges and staff training needs. On the other hand, hospital settings with altered diet and stress-induced hyperglycemia often pose challenges to tight glycemic control using conventional treatment tools. Integrating smarter glucose monitoring and insulin delivery devices into the increasingly technical hospital environment could reduce diabetes-related morbidity and mortality. This narrative review describes the most recent literature on the use of diabetes technology in the hospital and suggests avenues for further research. RECENT

findingsAdvanced diabetes technology has the potential to improve glycemic control in hospitalized people with and without diabetes, and could add particular value in certain conditions, such as nutrition therapy or perioperative management. Taken together, CGM allows for more accurate and patient-friendly follow-up and ad hoc titration of therapy. AID may also provide benefits, including improved glycemic control and reduced nursing workload. Before advanced diabetes technology can be used on a large scale in the hospital, further research is needed on efficacy, accuracy and safety, while implementation factors such as cost and staff training must also be overcome.

Indexed as

Blood Glucose Self-MonitoringDiabetes MellitusInsulin Infusion SystemsBlood GlucoseGlycemic ControlHospitalsHumansHypoglycemic AgentsInsulinBlood GlucoseHypoglycemic AgentsInsulinAutomated Insulin DeliveryContinuous Glucose MonitoringDiabetes TechnologyIn Hospital SettingInsulin Pump Therapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.